Hebei Lansheng Biotech Co., Ltd.
Beijing Multigrass Formulation Co., Ltd.

Bayer says glyphosate settlement talks delayed by coronavirus - Handelsblattqrcode

Apr. 3, 2020

Favorites Print
Apr. 3, 2020
Talks between Bayer AG (BAYGn.DE) and plaintiff lawyers to settle claims that the German company’s glyphosate -based weedkillers cause cancer have been slowed by the coronavirus pandemic, Bayer’s Chief Executive told daily Handelsblatt.

“This is about currently not being able to meet in person for talks. All this of course slows down the negotiations,” CEO Werner Baumann told the newspaper in an interview published on Thursday.

Court-appointed mediator Ken Feinberg told Reuters last month that the talks were slowed by the pandemic.

In the Handelsblatt interview, CEO Baumann reiterated remarks he made at the end of February that he was under no time pressure to strike a settlement deal and that he would not submit to a schedule or deadline.

Reporting by Ludwig Burger and Patricia Weiss

Source: Reuters

Picture 0/1200

More from AgroNews


2020 Latin America Focus 2020 Biologicals Special
2020 Formulation & Adjuvant Technology Annual Review 2019
Chinese issue of Annual Review 2019 2019 CRO & CRAO Manual
I wanna post a press Comment


Subscribe Email: *
Mobile Number:  


Picture 0/1200

Subscribe to daily email alerts of AgroNews.